The SJS/TEN Treatment Market is set for strong growth, powered by a 7.6% CAGR and a clear focus on improving patient outcomes for these severe reactions. With the market expected to surpass USD 12.5 billion by 2030, sustained investment in both pharmacological intervention and advanced sup